These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 3170132)

  • 41. Concentrative nucleoside transporter 3 as a prognostic indicator for favorable outcome of t(8;21)-positive acute myeloid leukemia patients after cytarabine-based chemotherapy.
    Song JH; Cho KM; Kim HJ; Kim YK; Kim NY; Kim HJ; Lee TH; Hwang SY; Kim TS
    Oncol Rep; 2015 Jul; 34(1):488-94. PubMed ID: 25955569
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Patients with t(8;21)(q22;q22) and acute myeloid leukemia have superior failure-free and overall survival when repetitive cycles of high-dose cytarabine are administered.
    Byrd JC; Dodge RK; Carroll A; Baer MR; Edwards C; Stamberg J; Qumsiyeh M; Moore JO; Mayer RJ; Davey F; Schiffer CA; Bloomfield CD
    J Clin Oncol; 1999 Dec; 17(12):3767-75. PubMed ID: 10577848
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A phase II trial of 1-(2-chloroethyl)-3-(2,6-dioxo-3-piperidyl)-1-nitrosourea (PCNU, NSC 95466) in recurrent malignant brain tumors.
    Feun LG; Stewart DJ; Leavens ME; Burgess MA; Savaraj N; Benjamin RS; Bodey GP
    J Neurooncol; 1983; 1(1):45-8. PubMed ID: 6678305
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Influence of UGT1A1 polymorphisms on the outcome of acute myeloid leukemia patients treated with cytarabine-base regimens.
    Chen P; Zhu KW; Zhang DY; Yan H; Liu H; Liu YL; Cao S; Zhou G; Zeng H; Chen SP; Zhao XL; Yang J; Chen XP
    J Transl Med; 2018 Jul; 16(1):197. PubMed ID: 30016963
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Translocation t(11;19)(q23;q13.1) without MLL Rearrangement in Acute Myeloid Leukemia: Heterogeneity of the 11q23 Breakpoints.
    Yamamoto K; Kawamoto S; Kakiuchi S; Yakushijin K; Matsuoka H; Minami H
    Acta Haematol; 2015; 134(2):76-9. PubMed ID: 25895667
    [No Abstract]   [Full Text] [Related]  

  • 46. [Cytarabine].
    Ota K
    Gan To Kagaku Ryoho; 1987 Oct; 14(10):2983-7. PubMed ID: 3478003
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Phase II study of PCNU in colorectal carcinoma.
    Mitchell EP; Killen JY; Smith FP; Willis LL; Schein PS; Woolley PV
    Cancer Treat Rep; 1981; 65(11-12):1129-30. PubMed ID: 7296558
    [No Abstract]   [Full Text] [Related]  

  • 48. Intensive timed chemotherapy protocol for 37 resistant or relapsing acute myeloid leukemias.
    Fière D; Campos L; Van HV; Guyotat D; Archimbaud E; Extra JM; Coiffier B; Viala JJ; Bryon PA; Milan JJ
    Cancer Treat Rep; 1986 Feb; 70(2):285-6. PubMed ID: 3456272
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Characteristics and outcomes of older patients with secondary acute myeloid leukemia according to treatment approach.
    Boddu PC; Kantarjian HM; Ravandi F; Garcia-Manero G; Verstovsek S; Jabbour EJ; Takahashi K; Bhalla K; Konopleva M; DiNardo CD; Ohanian M; Pemmaraju N; Jain N; Pierce S; Wierda WG; Cortes JE; Kadia TM
    Cancer; 2017 Aug; 123(16):3050-3060. PubMed ID: 28387922
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Therapy-related acute myeloid leukemia with inv(16) after successful therapy for de novo acute myeloid leukemia with t(8;21).
    Shao H; Yang Q; Wu C; Cen J; Chen S; Pan J
    Ann Hematol; 2017 Dec; 96(12):2127-2129. PubMed ID: 28840298
    [No Abstract]   [Full Text] [Related]  

  • 51. [Four cases of therapy-related leukemia in multiple myeloma].
    Natori K; Izumi H; Kaneko K; Ishihara S; Nagase D; Fujimoto Y; Kato M; Umeda M; Kuraishi Y
    Gan To Kagaku Ryoho; 2007 Jan; 34(1):121-4. PubMed ID: 17220686
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hematological and histopathological characteristics of leukemias induced by 1-alkyl-1-nitrosoureas in Donryu rats.
    Ogiu T
    Gan; 1978 Dec; 69(6):781-91. PubMed ID: 285909
    [No Abstract]   [Full Text] [Related]  

  • 53. [Efficacy of induction chemotherapy for patients with high-risk myelodysplastic syndrome (MDS) or MDS-transformed acute myeloid leukemia with CHG regimen and its comparison with regimen GAG and HA].
    Su JY; Chang CK; Zhang X; Zhou LY; Song LQ; Xu L; Wu LY; He Q; Li X
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Apr; 17(2):459-63. PubMed ID: 19379588
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [High dose ara-C therapy induced bradycardia in an acute myeloid leukemia patient with inv (16)(p13q22)].
    Kumagawa M; Suzuki K; Nagano M; Takamatsu Y; Suzumiya J; Tamura K
    Rinsho Ketsueki; 2003 Jun; 44(6):404-6. PubMed ID: 12884821
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Single nucleotide polymorphisms of cytarabine metabolic genes influence clinical outcome in acute myeloid leukemia patients receiving high-dose cytarabine therapy.
    Amaki J; Onizuka M; Ohmachi K; Aoyama Y; Hara R; Ichiki A; Kawai H; Sato A; Miyamoto M; Toyosaki M; Machida S; Kojima M; Shirasugi Y; Kawada H; Ogawa Y; Ando K
    Int J Hematol; 2015 Jun; 101(6):543-53. PubMed ID: 25735499
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Modulation of cytosine arabinoside (ara-C) and high-dose ara-C in acute leukemia.
    Zittoun R; Marie JP; Zittoun J; Marquet J; Haanen C
    Semin Oncol; 1985 Jun; 12(2 Suppl 3):139-43. PubMed ID: 3859928
    [No Abstract]   [Full Text] [Related]  

  • 57. Cytogenetics are a predictive factor of response to low dose Ara-C in acute myelogenous leukemia (AML) in the elderly.
    Fenaux P; Lai JL; Gardin C; Bauters F
    Leukemia; 1990 Apr; 4(4):312. PubMed ID: 2366585
    [No Abstract]   [Full Text] [Related]  

  • 58. Comparative chemotherapy of AKR lymphoma and human hematological neoplasia.
    Frei E; Schabel FM; Goldin A
    Cancer Res; 1974 Jan; 34(1):184-93. PubMed ID: 4520419
    [No Abstract]   [Full Text] [Related]  

  • 59. Treatment of patients with recurrent and primary refractory acute myelogenous leukemia using mitoxantrone and intermediate-dose cytarabine: a pharmacologically based regimen.
    Sternberg DW; Aird W; Neuberg D; Thompson L; MacNeill K; Amrein P; Shulman LN
    Cancer; 2000 May; 88(9):2037-41. PubMed ID: 10813714
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Acute myeloid leukemia complicating multiple myeloma: a case successfully treated with etoposide, thioguanine, and cytarabine.
    Erikci AA; Ozturk A; Tekgunduz E; Sayan O
    Clin Lymphoma Myeloma; 2009 Aug; 9(4):E14-5. PubMed ID: 19717372
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.